US2021268058A1PendingUtilityA1
Neem for treatment of rls
Est. expiryJun 26, 2038(~11.9 yrs left)· nominal 20-yr term from priority
Inventors:Martin Vorderwülbecke
A61K 36/58A61P 25/14A61K 31/58A61K 45/06A61K 2236/15A61K 9/0014A61K 31/343A61K 31/352
39
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A pharmaceutical product of the present invention contains plant parts obtained from the neem tree Azadirachta indica or active ingredients derived from such plant parts for use in treating, preventing and/or alleviating symptoms of restless legs syndrome.
Claims
exact text as granted — not AI-modified1 . Pharmaceutical product containing plant parts obtained from the neem tree Azadirachta indica or active ingredients derived from such plant parts for use in treating, preventing and/or alleviating symptoms of restless legs syndrome (RLS).
2 . Pharmaceutical product for the use according to claim 1 , wherein the plant parts are derived from leaves, flowers, seed, gum, fruit or bark of the neem tree.
3 . Pharmaceutical product for use according to claim 1 , comprising crushed or shredded neem tree leaves.
4 . Pharmaceutical product for use according to claim 1 , wherein active ingredients are obtained by extraction and can be included as crude or complex mixture of substances or as partly or fully isolated substances.
5 . Pharmaceutical product for use according to claim 4 , wherein the active ingredients include at least one of nimbin, nimbinin, nimbidin, salannin, meliantriol and azadirachtin.
6 . Pharmaceutical product for use according to claim 1 , which is provided in a form suitable for internal use.
7 . Pharmaceutical product for use according to claim 6 , in dry or liquid form, especially a powder, granules, pills, tablets, lozenges, capsules or an emulsion, a suspension, an extract, an oil, a tea or tea preparation.
8 . Pharmaceutical product for use according to claim 1 , further containing additional pharmaceutically active substances or drugs, preferably analgesic and/or antiphlogistic substances.
9 . Pharmaceutical product for use according to claim 1 , further comprising substances selected from pharmaceutically acceptable adjuvants and excipients, especially fillers, lubricants, glidants, binders, compounds which ensure easy disintegration, disaggregation and dissolution of a tablet in the stomach or the intestine, compounds providing for sustained release, sweeteners, sugar, varnish or wax, flavor, coloring agents or preservatives.
10 . Pharmaceutical product for use according to claim 1 , comprising oil obtained from neem seeds.
11 . Pharmaceutical product for use according to claim 1 , which is provided in a form suitable for external use.
12 . Pharmaceutical product for use according to claim 11 , which is provided in the form of a paste, cream, balm, ointment, emulsion, suspension, gel, spray or foam.
13 . Pharmaceutical product for use according to claim 11 , which is capable of penetrating the skin and/or being absorbed into the blood circulation.
14 . Pharmaceutical product for use according to claim 11 , further comprising additional pharmaceutically active substances or drugs, preferably analgesic and/or antiphlogistic substances.
15 . Pharmaceutical product for use according to claim 11 , further comprising substances selected from pharmaceutically acceptable adjuvants, excipients and preservatives.Join the waitlist — get patent alerts
Track US2021268058A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.